Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-24 @ 6:44 PM
Study NCT ID:
NCT03820557
Status:
COMPLETED
Last Update Posted:
2025-04-29
First Post:
2019-01-25
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Study Overview
Official Title:
Increasing Shared Decision Making and Patient Participation in Lung Cancer Clinical Trials (Free to Breathe)
Status:
COMPLETED
Status Verified Date:
2025-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial studies how well the Decision Counseling Program works in increasing patient-physician shared decision making and participation in clinical trials for lung cancer patients. Decision aids help provide patients with information that may help them select a course of action related to their cancer care when more than one alternative is available. It also encourages shared decision making allowing patients and their providers to make health decisions together. Determining how patients make decisions about participating in a clinical trial may help doctors facilitate patient decision making and improve participation in lung cancer clinical trials.
Detailed Description:
PRIMARY OBJECTIVES:
I. Facilitate patient deliberation about participation in a lung cancer clinical trial using the Decision Counseling Program (DCP).
SECONDARY OBJECTIVES:
I. Document the extent to which patient values and preferences are incorporated into physician-patient shared decision making (SDM) about cancer clinical trials.
II. Assess changes in patient knowledge, anxiety, and decisional conflict related to clinical trial participation.
III. Characterize patient and physician experience with intervention exposure.
I. Facilitate patient deliberation about participation in a lung cancer clinical trial using the Decision Counseling Program (DCP).
SECONDARY OBJECTIVES:
I. Document the extent to which patient values and preferences are incorporated into physician-patient shared decision making (SDM) about cancer clinical trials.
II. Assess changes in patient knowledge, anxiety, and decisional conflict related to clinical trial participation.
III. Characterize patient and physician experience with intervention exposure.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| JT 10803 | OTHER | JeffTrial Number | View |